1475TiP Fruquintinib in combination with sintilimab and CAPEOX as first-line treatment for advanced G/GEJ cancer: A phase Ib/II clinical trial (FUNCTION)
2024 · Annals of Oncology · 1 citations
https://doi.org/10.1016/j.annonc.2024.08.2238
B
B. Chen
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
10
Papers
8
Citations
1
h-index
0
i10-index
B. Chen is an academic researcher from National Institute of Genetics. The author has contributed to research in topics: Genetic diversity and population structure & Cancer Genomics and Diagnostics & Genomics and Phylogenetic Studies. The author has an h-index of 1, co-authored 9 publications.
ORCID: 0000-0002-1591-6906Papers by this author
worksResearch topics
topicsChat about Author
Papers
Chat
Click to start Chat